Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04146532 · ClinicalTrials.gov registry record · Early Phase 1
Aspirin Effects on Emotional Reactions
A Early Phase 1 study, sponsored by Ohio State University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 268
- Enrollment target
NCT04146532: Completed Early Phase 1 study, sponsored by Ohio State University.
NCT04146532 is a Early Phase 1 study that has completed, run by Ohio State University. The registered enrollment target is 268 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (406% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04146532, a Early Phase 1 study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 268 participants
- Enrollment target
Study Summary
The aim of this study is to determine whether the drug aspirin has effects on emotional reactivity, emotional memory, and risk-taking behaviors.
Primary Outcome
Changes in self-reported evaluations of valence on a 1 to 7 scale and felt reactions to emotional images on a 1-7 scale.
Interventions
- DRUG Placebo
- DRUG Aspirin 500 MG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 268 participants |
| Start Date | 2019-10-08 |
| Est. Completion | 2022-04-15 |
| Phase | Early Phase 1 |
What the finished NCT04146532 record still lists
NCT04146532 is an interventional study that assigns participants to a tested intervention. The registered 268 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (406% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04146532 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04146532 about?
NCT04146532 is a clinical study titled "Aspirin Effects on Emotional Reactions". The aim of this study is to determine whether the drug aspirin has effects on emotional reactivity, emotional memory, and risk-taking behaviors.
What is the current status of trial NCT04146532?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 268 participants. The study started on 2019-10-08. Estimated completion is 2022-04-15.
What interventions are being tested in trial NCT04146532?
The interventions under investigation include: Placebo (DRUG), Aspirin 500 MG (DRUG).
Who is sponsoring clinical trial NCT04146532?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04146532's enrollment target sits among peer trials
268 43rd of 2000 higher than 1,958 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05000632 · 268 participants · NA
Smoke Free SafeCare: Establishing a Smoke Free Home in CPS-involved Families
- NCT05797831 · 268 participants · Phase 2
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
- NCT05997381 · 268 participants · NA
BioBrace® Implant for Arthroscopic Repair of Full Thickness Rotator Cuff Tears
- NCT06233461 · 268 participants · Phase 2
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI